Dr Horton Stock Return On Equity
| HO2 Stock | EUR 164.48 6.74 4.27% |
DR Horton fundamentals help investors to digest information that contributes to DR Horton's financial success or failures. It also enables traders to predict the movement of HO2 Stock. The fundamental analysis module provides a way to measure DR Horton's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DR Horton stock.
HO2 |
DR Horton Company Return On Equity Analysis
DR Horton's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current DR Horton Return On Equity | 0.31 |
Most of DR Horton's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DR Horton is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, DR Horton has a Return On Equity of 0.3128. This is 91.31% lower than that of the Consumer Cyclical sector and 94.44% lower than that of the Residential Construction industry. The return on equity for all Germany stocks is notably lower than that of the firm.
HO2 Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DR Horton's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DR Horton could also be used in its relative valuation, which is a method of valuing DR Horton by comparing valuation metrics of similar companies.DR Horton is currently under evaluation in return on equity category among its peers.
HO2 Fundamentals
| Return On Equity | 0.31 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 31.96 B | |||
| Shares Outstanding | 343.39 M | |||
| Shares Owned By Insiders | 14.53 % | |||
| Shares Owned By Institutions | 88.85 % | |||
| Price To Earning | 9.45 X | |||
| Price To Book | 1.53 X | |||
| Price To Sales | 0.87 X | |||
| Revenue | 33.48 B | |||
| Gross Profit | 10.07 B | |||
| EBITDA | 7.65 B | |||
| Net Income | 5.86 B | |||
| Cash And Equivalents | 637.7 M | |||
| Cash Per Share | 1.71 X | |||
| Total Debt | 6.07 B | |||
| Debt To Equity | 37.90 % | |||
| Current Ratio | 7.18 X | |||
| Book Value Per Share | 58.71 X | |||
| Cash Flow From Operations | 561.8 M | |||
| Earnings Per Share | 15.11 X | |||
| Price To Earnings To Growth | 1.80 X | |||
| Target Price | 111.69 | |||
| Number Of Employees | 13.24 K | |||
| Beta | 1.53 | |||
| Market Capitalization | 30.06 B | |||
| Total Asset | 30.35 B | |||
| Z Score | 3.4 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 0.87 % | |||
| Net Asset | 30.35 B | |||
| Last Dividend Paid | 0.93 |
About DR Horton Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DR Horton's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DR Horton using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DR Horton based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in HO2 Stock
When determining whether DR Horton offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DR Horton's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Horton Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Horton Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in HO2 Stock please use our How to Invest in DR Horton guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.